Zhongzhi Pharmaceutical Holdings Limited (3737.HK)
HKD 0.89
(-2.2%)
HKD 0.89
(-2.2%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 330.01 Million CNY | 2.2% |
| 2022 | 322.9 Million CNY | 20.46% |
| 2021 | 268.05 Million CNY | 8.47% |
| 2020 | 247.12 Million CNY | 24.16% |
| 2019 | 199.03 Million CNY | 11.2% |
| 2018 | 178.99 Million CNY | 29.78% |
| 2017 | 137.92 Million CNY | 13.91% |
| 2016 | 121.08 Million CNY | 21.21% |
| 2015 | 99.89 Million CNY | 12.91% |
| 2014 | 88.47 Million CNY | -18.79% |
| 2013 | 108.94 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 344.37 Million CNY | 4.35% |
| 2023 Q4 | 330.01 Million CNY | 9.18% |
| 2023 FY | 330.01 Million CNY | 2.2% |
| 2023 Q2 | 302.27 Million CNY | -6.39% |
| 2022 FY | 322.9 Million CNY | 20.46% |
| 2022 Q2 | 256.62 Million CNY | -4.26% |
| 2022 Q4 | 322.9 Million CNY | 25.83% |
| 2021 Q2 | 265.37 Million CNY | 7.39% |
| 2021 FY | 268.05 Million CNY | 8.47% |
| 2021 Q4 | 268.05 Million CNY | 1.01% |
| 2020 FY | 247.12 Million CNY | 24.16% |
| 2020 Q4 | 247.12 Million CNY | 8.82% |
| 2020 Q2 | 227.08 Million CNY | 14.09% |
| 2019 FY | 199.03 Million CNY | 11.2% |
| 2019 Q4 | 199.03 Million CNY | 9.17% |
| 2019 Q2 | 182.32 Million CNY | 1.86% |
| 2018 Q4 | 178.99 Million CNY | 17.13% |
| 2018 FY | 178.99 Million CNY | 29.78% |
| 2018 Q2 | 152.81 Million CNY | 10.8% |
| 2017 Q4 | 137.92 Million CNY | -2.73% |
| 2017 Q2 | 141.8 Million CNY | 17.11% |
| 2017 FY | 137.92 Million CNY | 13.91% |
| 2016 Q2 | 110.17 Million CNY | 10.29% |
| 2016 Q4 | 121.08 Million CNY | 9.9% |
| 2016 FY | 121.08 Million CNY | 21.21% |
| 2015 Q4 | 99.89 Million CNY | 2.75% |
| 2015 FY | 99.89 Million CNY | 12.91% |
| 2015 Q2 | 97.21 Million CNY | 9.89% |
| 2014 Q4 | 88.47 Million CNY | 0.0% |
| 2014 FY | 88.47 Million CNY | -18.79% |
| 2013 FY | 108.94 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -2605.723% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | 76.235% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -4442.56% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | -7.114% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | 23.569% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | -10.705% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -425.321% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -235.84% |
| PuraPharm Corporation Limited | 175.59 Million HKD | -87.94% |
| SSY Group Limited | 1.08 Billion HKD | 69.62% |
| JBM (Healthcare) Limited | 91.58 Million HKD | -260.34% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | -3.826% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 99.06% |